Loading
Total declarations
Companies
▲ Purchases (21 ops.)
▼ Sales (0 ops.)
Latest filing published 01 Jul 2015 for QLT INC/BC, €193k.
Insider track record
Disclosed buys
21
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
21
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +1.7%Entry US$353.10 · Close at T+365 US$359.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Geoffrey F. Cox: trading record in brief
This profile gathers the share dealings of Geoffrey F. Cox across 3 companies, led by GTC Biotherapeutics Inc, QLT Inc/BC and Vaxart, Inc. Between 10 March 2006 and 29 June 2015, the trades on record add up to 47 filings.
Every open-market trade on record is a purchase: 21 purchases worth €97k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 10 share grants and 4 option exercises.
A typical purchase (the median) is worth €4,223.
Most recently, on 1 July 2015, the filings show an option exercise worth €193k in QLT Inc/BC. The most recent open-market purchase was published on 24 May 2010, 5,996 days ago. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Geoffrey F. Cox
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
60,000 shares@ US$3.61Common SharesSEC:0001455244-15-000023:1
4,000 sharesCommon SharesSEC:0001578259-15-000046:0
2,000 sharesCommon SharesSEC:0001578259-14-000011:0
1,908 shares@ US$5.24Common StockSEC:0001491877-10-000004:0
Canonical exit: 18 Aug 2010 (T+90)
35,286 shares@ US$1.21Common StockSEC:0000908662-09-000335:0
11,193 shares@ US$1.21Common StockSEC:0000908662-09-000335:1
31,626 shares@ US$1.21Common StockSEC:0000908662-09-000330:0
2,331 shares@ US$2.66Common StockSEC:0000908662-09-000262:0
10,800 shares0Common StockSEC:0000908662-09-000032:0
43,600 shares@ US$0.17Common StockSEC:0000908662-08-000258:0
Canonical exit: 19 Feb 2009 (T+90)
40,900 shares@ US$0.16Common StockSEC:0000908662-08-000258:1
Canonical exit: 19 Feb 2009 (T+90)
1,500 shares@ US$0.15Common StockSEC:0000908662-08-000258:2
Canonical exit: 19 Feb 2009 (T+90)
61,200 shares0Common StockSEC:0000908662-08-000197:0
7,400 shares@ US$0.46Common StockSEC:0000908662-08-000112:0
Canonical exit: 12 Jun 2008 (T+90)
63,100 shares@ US$0.47Common StockSEC:0000908662-08-000112:1
Canonical exit: 12 Jun 2008 (T+90)
13,740 shares@ US$0.48Common StockSEC:0000908662-08-000112:2
Canonical exit: 12 Jun 2008 (T+90)
3,900 shares@ US$0.49Common StockSEC:0000908662-08-000112:3
Canonical exit: 12 Jun 2008 (T+90)
12,260 shares@ US$0.50Common StockSEC:0000908662-08-000112:4
Canonical exit: 12 Jun 2008 (T+90)
73,442 shares0Common StockSEC:0000908662-08-000103:0
1,000 shares@ US$0.90Common StockSEC:0000908662-07-000400:0
Canonical exit: 12 Mar 2008 (T+90)
7,865 shares@ US$0.89Common StockSEC:0000908662-07-000400:1
Canonical exit: 12 Mar 2008 (T+90)
1,000 shares@ US$0.8894Common StockSEC:0000908662-07-000400:2
Canonical exit: 12 Mar 2008 (T+90)
900 shares@ US$0.88Common StockSEC:0000908662-07-000400:3
Canonical exit: 12 Mar 2008 (T+90)
1,253 shares@ US$0.884Common StockSEC:0000908662-07-000360:0
7,700 shares@ US$1.02Common StockSEC:0000908662-07-000291:0
Canonical exit: 11 Nov 2007 (T+90)
25 of 41 declarations
